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UNIVERSITI Malaysia Sa- 
rawak (UNIMAS) has re- 
corded several milestones in 
research, especially in the 
conservation of biodiversit-' 
and development of bio- 
technology. 
An important research 
facility at UN1MAS is the 
Institute of Biodiversity and 
Environmental Conservation 
(IBEC), which focuses, often 
with local and international 
collaboration, on the ecology 
and conservation of biota 
and threatened habitats in 
Borneo. 
This has resulted in the 
creation of databases on 
terrestrial and marine Me- 
diversity, such as the dis- 
covery of montane endemics 
at Mount Murud, which 
were previously recorded 
only on Mount Kinabalu. 
In a recent expedition to 
Mount Murud, IBEC scien- 
tists led by Associate Pro- 
fessor Dr Fatimah Abang 
discovered the montane 
butterfly Ptychaadra tnlboti, 
which is endemic to Borneo, 
and the first record for the 
mountain. 
According to IBEC her- 
petologist Associate Profes- 
sor Dr Indraneil Das, several 
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new taxa offrogs, especially of 
the Polypedates and Pelo- 
phyrene genera, were also 
collected. 
The endemic bird, 
Mountain Blackeye, was 
abundant at 2,000m above 
sea level while the Mountain 
Treepie was common at a 
lower elevation. 
In environmental conser- 
vation, IBEC scientist As- 
sociate Professor Dr Lau 
Seng developed a voltam- 
metric method to detect ar- 
senic speciation in fresh 
water. This method has 
proven to be cheap, reliable 
and simple to operate. 
Future research at IBEC 
will continue to focus tropical 




ecology and coastal marine 
ecology. 
Ecosystems that are 
unique and threatened by 
human activities - will be 
priority areas for fieldwork. 
Meanwhile, in line with 
Vision 2020 and the forma- 
tion of Biovalley Malaysia 
(BVM), UNIMAS is under- 
taking research geared to- 
wards the development of 
biotechnology-based activi- 
ties and product develop- 
ment to help stimulate the 
industry in the Malaysia. 
It is interested in provid- 
ing input to help develop 
Malaysia's biotechnology 
industry in the future, in- 
cluding developing vaccines 
against dengue and Japa- 
nese Encephalitis (JE). 
Its Institute of Health and 
Community Medicine has 
been collaborating with two 
biotechnology companies to 
develop genetically-engi- 
neered vaccines against 
dengue and JE. 
One is Malaysian com- 
pany Venture Technologies 
Sdn Bhd (VT), which 10 
years ago accomplished a 
world first by producing a 
dengue diagnostic kit in 
collaboration with a bio- 
technology company in Sin- 
gapore. 
Since then VT has pro- 
duced kits for the diagnosis of 
JE and has been involved in 
research for the develop- 
ment of a dengue and a JE 
vaccine. Together with 
Bavarian Nordic, a bio- 
technology company listed on 
the Co-penhagen stock 
exchange, VT and UNIMAS 
have produced prototype 
vaccines against dengue and 
JE and these are undergoing 
pre-clinical testing at the uni- 
versity. 
Both vaccines are based 
on genetically engineering- 
important genes of these 
viruses into a well-tested 
virus vaccine called Modified 
VacciniaAnkara (MVA). 
MVA was developed as a 
vaccine against smallpox and 
has a strong record of safety 
and is considered a strong 
candidate to deliver new 
recombinant viral vaccines 
that are safe. UNIMAS also 
has in the pipeline 
biotechnology-based diag- 
nostics and vaccine candi- 
dates for development and 
possible commercialisation. 
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